News & Events

Welcome to Dalton Pharma Services News and Events section. On this page you will find our current and past news releases, and a list of event happenings. If you can't find what you are looking for, contact us and we will be happy to provide you with assistance.
Download our Corporate Brochure
Resource Centre
Date   Articles
Feb 22, 2010   Dalton and Boehringer Announce the Renewal of their Chemistry Services Agreement
Feb 1, 2010   Dalton Announces Successful Completion of Health Canada Inspection
Oct 29, 2009   BIKAM and Dalton Medicinal Chemistry Expand and Renew Research Agreement
Sep 21, 2009   Dalton Pharma Services Adds Formulation Development Services
May 11, 2009   Dalton and ProCitius Announce Strategic Alliance to Provide Contract Chemistry Services
Mar 23, 2009   Dalton and BioRelix announced expansion to discover and develop new therapeutics.
Feb 23, 2009   Dalton and Boehringer Announce Renewal Chemistry Services Agreement
Oct 22, 2008   Dalton Pharma Services and Myelin Repair Foundation Enter into Chemistry Collaboration
July 15, 2008
  Dalton Pharma Services Expands its Contract Analytical Services
May 6, 2008
  Dalton Licenses Thermo Fisher Scientific Technology to Produce Polynucleotides
Mar 3, 2008
 
Jan 23, 2008
 
Jan 22, 2008
 
Nov 13, 2007
  BioRelix and Dalton jointly announced a research collaboration to discover new therapeutics
Oct 29, 2007
 
June 14, 2007
  Dalton and X-GEN Pharmaceuticals Inc. enter into a manufacturing services agreement
Mar 23, 2007
  Dalton and Boehringer Ingelheim (Canada) Ltd. enter into a Medicinal Agreement
Mar 1, 2007
  Dalton and Affectis Pharmaceuticals of Germany enter into a Contract Services Agreement
Jan 26, 2007
  Health Canada approves Dalton for the delivery of commercial products
Aug 31, 2006
  Dalton Pharma Services Launches Expanded Medicinal Chemistry Services
Apr 12, 2006
  Dalton Announces Completion of GMP Oligonucleotide Manufacturing Facility
Mar 31, 2005
  Dalton Announces Operating Name Change
Oct 25, 2004
  Dalton Chemical Labs Inc. Completes it's $1.4 Million Expansion to it's Facilities
May 25, 2004
  Stellar Inc. Moves it's Manufacturing to Dalton Inc.
May 17, 2003
  The Fine Art of Canadian Conversation
May 03, 2003
  Race on to Realize Value of SARS Patent
May 01, 2003
  CEO's Talk: From Job Security to Youth Mobility, Six Canadian CEO's Share Retention Strategies
Jun 30, 2002
  Triad's Biotech Identity is Beginning to Emerge
Jun 20, 2002
  Key Questions to Ask When Outsourcing Pre-clinical Development Services
Jun 04, 2002
  Lorus Receives Fast Track Designation from FDA for Virulizin - Treatment of Pancreatic Cancer
Mar 12, 2001
  Dalton Chemical Laboratories Inc. is to Manufacture Drug for Lorus Therapeutics
Apr 12, 2000
  Dalton Chemical Laboratories... On the Move!
Jul 22, 1999
  Custom Peptide Synthesis Launch